166 related articles for article (PubMed ID: 6633677)
1. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
Costall B; Domeney AM; Naylor RJ
Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
[TBL] [Abstract][Full Text] [Related]
2. The continuity of dopamine receptor antagonism can dictate the long-term behavioural consequences of a mesolimbic infusion of dopamine.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1985 Mar; 24(3):193-7. PubMed ID: 3990920
[TBL] [Abstract][Full Text] [Related]
3. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
[TBL] [Abstract][Full Text] [Related]
4. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.
Costall B; Domeney AM; Naylor RJ
Psychopharmacology (Berl); 1984; 82(3):174-80. PubMed ID: 6144126
[TBL] [Abstract][Full Text] [Related]
5. Behavioural consequences of the infusion of dopamine into the nucleus accumbens of the common marmoset (Callithrix jacchus).
Barnes NJ; Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1987 Sep; 26(9):1327-35. PubMed ID: 2890118
[TBL] [Abstract][Full Text] [Related]
6. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
[TBL] [Abstract][Full Text] [Related]
7. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
Weiss F; Ettenberg A; Koob GF
Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
[TBL] [Abstract][Full Text] [Related]
8. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
Barnes JC; Barnes NJ; Barnes NM; Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1987 Jul; 26(7A):693-700. PubMed ID: 3114665
[TBL] [Abstract][Full Text] [Related]
9. Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate.
Jones DL; Berg SL; Dorris RL; Dill RE
Pharmacol Biochem Behav; 1981 Aug; 15(2):243-6. PubMed ID: 7198267
[TBL] [Abstract][Full Text] [Related]
10. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
Barnes JC; Costall B; Domeney AM; Naylor RJ
Psychopharmacology (Berl); 1986; 89(3):311-6. PubMed ID: 3088656
[TBL] [Abstract][Full Text] [Related]
11. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment.
Lane RF; Blaha CD; Phillips AG
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):291-9. PubMed ID: 2819952
[TBL] [Abstract][Full Text] [Related]
13. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
Costall B; Eniojukan JF; Naylor RJ
Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
[TBL] [Abstract][Full Text] [Related]
14. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
[TBL] [Abstract][Full Text] [Related]
15. Enhanced dopamine receptor activation in accumbens and frontal cortex has opposite effects on medial forebrain bundle self-stimulation.
Olds ME
Neuroscience; 1990; 35(2):313-25. PubMed ID: 2199840
[TBL] [Abstract][Full Text] [Related]
16. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
Morgenstern R; Fink H
J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
[TBL] [Abstract][Full Text] [Related]
17. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
Swerdlow NR; Amalric M; Koob GF
Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.
Debonnel G; Gaudreau P; Quirion R; de Montigny C
J Neurosci; 1990 Feb; 10(2):469-78. PubMed ID: 2137531
[TBL] [Abstract][Full Text] [Related]
19. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
Boldry RC; Uretsky NJ
Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
[TBL] [Abstract][Full Text] [Related]
20. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
Johnels B
Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
